Overweight Or Obesity clinical trials

Explore recruiting overweight or obesity clinical trials.

Recruiting overweight or obesity studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Overweight Or Obesity trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy and safety of NNC0487-0111 s.c. once-weekly in participants with overweight or obesity, and obstructive sleep apnoea treated with positive airway pressure (AMAZE 4)

Poland, Spain, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Efficacy and safety of NNC0487-0111 s.c. once-weekly in participants with overweight or obesity, and knee osteoarthritis (AMAZE 6)

Greece, Poland, Spain, Bulgaria, Italy, Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

Efficacy and safety of NNC0487-0111 s.c. once-weekly in participants with overweight or obesity, and obstructive sleep apnoea not treated with positive airway pressure (AMAZE 3)

Denmark, Poland, Spain, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Efficacy and safety of NNC0487-0111 s.c. once-weekly compared to semaglutide s.c. once-weekly in participants with overweight or obesity, and type 2 diabetes (AMAZE 8)

Germany, Croatia, Portugal, Hungary, Bulgaria, Romania +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Efficacy and safety of NNC0487-0111 s.c. once-weekly in participants with overweight or obesity, and type 2 diabetes (AMAZE 2)

Italy, Croatia, Hungary, Slovakia, Romania

Therapeutic confirmatory (Phase III) EU CTIS Study details

Efficacy and safety of NNC0487-0111 s.c. once-weekly in participants with overweight or obesity, and knee osteoarthritis (AMAZE 5)

Italy, Greece, Spain, Bulgaria, Denmark, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Overweight Or Obesity trials by city

Overweight Or Obesity in Toronto Overweight Or Obesity in Vancouver Overweight Or Obesity in Montreal Overweight Or Obesity in Calgary Overweight Or Obesity in Edmonton Overweight Or Obesity in Ottawa Overweight Or Obesity in Winnipeg Overweight Or Obesity in Quebec City Overweight Or Obesity in Hamilton Overweight Or Obesity in Kitchener Overweight Or Obesity in London Overweight Or Obesity in Halifax Overweight Or Obesity in New York Overweight Or Obesity in Los Angeles Overweight Or Obesity in Chicago Overweight Or Obesity in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease